Anti-CD133 antibody [EPR16508]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
5
(1 Review)
|
(51 Publications)
Rabbit Recombinant Monoclonal CD133 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 51 publications.
View Alternative Names
CD133, PROML1, MSTP061, PROM1, Prominin-1, Antigen AC133, Prominin-like protein 1
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD133 antibody [EPR16508] (AB222782)
Immunohistochemical analysis of paraffin-embedded human kidney tissue labeling CD133 with ab222782 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ready to use). Membranous staining on parietal layer of Bowman's capsule and apical staining on renal tubules in human kidney (PMID : 19092120). Counter stained with Hematoxylin. Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ready to use).
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD133 antibody [EPR16508] (AB222782)
Immunohistochemical analysis of paraffin-embedded human pancreas tissue labeling CD133 with ab222782 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP)(ready use). Apical/endoluminal staining of human pancreatic ducts, and negative on Langerhans cells of the islets (PMID : 18261235). Counter stained with Hematoxylin. Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP)(ready to use).
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD133 antibody [EPR16508] (AB222782)
Immunohistochemical analysis of paraffin-embedded human bladder cancer tissue labeling CD133 with ab222782 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) (ready to use). Membranous staining on human bladder cancer tumor cells (PMID : 22899341). Counter stained with Hematoxylin. Perform heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0).
Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) (ready to use).
- WB
Lab
Western blot - Anti-CD133 antibody [EPR16508] (AB222782)
ab222782 was shown to react with CD133 in wild-type HAP1 cells in western blot. Loss of signal was observed when PROM1 knockout sample was used. Membranes were blocked in 3 % milk in TBS-T (0.1 % Tween®) before incubation with ab222782 overnight at 4°C at a 1 in 2000 dilution. Blots were incubated with HRP conjugated Goat anti-Rabbit (H+L) secondary antibody at 1/5000 for 1 hour at room temperature before development with ECL reagent and imaging.
All lanes:
Western blot - Anti-CD133 antibody [EPR16508] (ab222782) at 1/2000 dilution
Lane 1:
Wild-type HAP1 cell lysate at 40 µg
Lane 2:
PROM1 knockout HAP1 cell lysate at 40 µg
Predicted band size: 97 kDa
Observed band size: 110 kDa
false
Exposure time: 8min
- WB
Lab
Western blot - Anti-CD133 antibody [EPR16508] (AB222782)
Blocking buffer : 5% NFDM/TBST.
The MW observed is consistent with the literature (PMID 20717901; PMID 18645205).
All lanes:
Western blot - Anti-CD133 antibody [EPR16508] (ab222782) at 1/2000 dilution
Lane 1:
Human fetal pancreas lysate at 20 µg
Lane 2:
Human fetal kidney lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 97 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-CD133 antibody [EPR16508] (AB222782)
Blocking buffer : 5% NFDM/TBST.
The MW observed is consistent with the literature (PMID 20717901; PMID 18645205).
All lanes:
Western blot - Anti-CD133 antibody [EPR16508] (ab222782) at 1/10000 dilution
All lanes:
NCCIT (Human pluripotent embryonic carcinoma epithelial cell), whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 97 kDa
false
Exposure time: 15s
- WB
Lab
Western blot - Anti-CD133 antibody [EPR16508] (AB222782)
Negative control : HeLa (PMID 9389721).
The MW observed is consistent with the literature (PMID 20717901; PMID 18645205).
Blocking buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-CD133 antibody [EPR16508] (ab222782) at 1/10000 dilution
Lane 1:
Caco-2 (Human colorectal adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 2:
HT-29 (Human colorectal adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Lane 3:
HeLa (Human cervix adenocarcinoma epithelial cell), whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 97 kDa
false
Exposure time: 5s
- WB
CiteAb
Western blot - Anti-CD133 antibody [EPR16508] (AB222782)
CD133 western blot using anti-CD133 antibody [EPR16508] ab222782. Publication image and figure legend from Shi, M., An, G., et al., 2023, Cancers (Basel), PubMed 37173968.
ab222782 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab222782 please see the product overview.
Correlation between UVRAG expression and therapeutic resistance. (A) Relative expression of UVRAG in HCT8, HCT8-5Fu, and HCT8-60Gy cells. (B) The sensitivity of HCT8-CON and HCT8-UVRAG cells to radiotherapy. (C) UVRAG knockdown increased 5-Fu sensitivity. (D) UVRAG overexpression decreased 5-Fu sensitivity. (E) Relative mRNA expression of UVRAG in HCT116 and HCT116-self cells. (F) Relative mRNA expression of UVRAG in HCT116 DCLK- and HCT116 DCLK+ cells. (G) Western blot of PD-L1, UVARG, ABCG2, BMI1, and SP1 after upregulating UVARG or downregulating UVRAG. The uncropped blots are shown in Figure S1. (H) Spheroid formation in UVRAG overexpressed HCT116 and its control cells. (I) Stem cell score evaluated via ssGSEA in patients with UVRAG higher expression and UVARG lower expression. Independent-samples t-test (A,E,F). Mann Whitney U test (I). * p < 0.05, ** p < 0.01.
false
Related conjugates and formulations (1)
-
Anti-CD133 antibody [EPR16508] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CD133 is involved in maintaining the cellular architecture and signaling processes. It plays a role in cellular differentiation and proliferation while acting as a part of larger protein complexes on the cell surface. This protein is notable as it contributes significantly to the regulation of stem cell properties supporting the growth and repair in various tissues. Anti-CD133 antibodies are valuable tools in studying these functions due to their specificity in targeting this marker.
Pathways
CD133 participates in cellular signaling and transport pathways vital for intercellular communication and homeostasis. It interacts within pathways related to cell polarity and asymmetric division both essential for tissue development and maintenance. CD133 is associated with proteins like CD133/1 and CD133/2 which further highlights its involvement in these complex biological networks and on pathways such as the Wnt signaling pathway which regulates gene expression associated with cell proliferation and differentiation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (51)
Recent publications for all applications. Explore the full list and refine your search
BioFactors (Oxford, England) 51:e70029 PubMed40546096
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of experimental & clinical cancer research : CR 44:112 PubMed40181456
2025
Applications
Unspecified application
Species
Unspecified reactive species
Discover oncology 16:403 PubMed40140224
2025
Applications
Unspecified application
Species
Unspecified reactive species
Translational cancer research 14:1265-1281 PubMed40104739
2025
Applications
Unspecified application
Species
Unspecified reactive species
Thoracic cancer 16:e70023 PubMed40051202
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Kaohsiung journal of medical sciences 41:e12930 PubMed39789998
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 21:382-399 PubMed39744423
2025
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 28:456 PubMed39478737
2024
Applications
Unspecified application
Species
Unspecified reactive species
Atherosclerosis 397:118549 PubMed39141976
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 54: PubMed38994756
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com